Orang’o, E.O., et al., 2019. Is there value to sub-specialty training in sub-Saharan Africa?. Southern African Journal of Gynaecological Oncology, 11(1), p.21-23.

Brown, D.R., et al., 2018. AMPATH Oncology: Baseline HPV detection in Kenyan women enrolled in a longitudinal study of modifiable factors predicting cervical dysplasia. Journal of Clinical Oncology, 36(15_suppl), p.5533-5533.

Orang'o, E.O. & Rosen, B., 2018. Building Capacity/Sustainability for Comprehensive Cancer Care in a Low Resource Country. In Toronto Global Cancer Control Conference . March 2, 2018. Toronto, Canada.

Loehrer, P.J., et al., 2018. Capacity building in sub-Saharan Africa: models of care. The Lancet, (www.thelancet.com/lancetgh).

Rosen, B., et al., 2018. Home HPV testing in rural Kenya; Improving capacity for cervical cancer screening and prevention. In The 48TH SGO Annual Meeting. March 10, 2018.

Orang'o, E.O., et al., 2018. The impact of VIA screen and treatment with cryotherapy or LEEP in patients with HIV-infected and HIV-uninfected patients with cervical intraepithelial neoplasia (CIN). In NCI U54 Meeting, Lilongwe, Malawi.

Shurie, S., et al., 2018. Levonorgestrel only emergency contraceptive use and risk of ectopic pregnancy in Eldoret Kenya: a case-control study. Pan African Medical Journal, 31(214), p.doi:10.11604/pamj.2018.31.214.17484.

Kiptoo, S., 2018. Loss to Follow-Up in a Cervical Cancer Screening and Treatment Program in Western Kenya. Journal of Global Oncology , 4_suppl_2(97s-97s).

Oyiengo, V.N., et al., 2018. [PDF] from researchgate.net Prenatal Cervical Cancer Screening Using Visual Inspection with Acetic Acid in a Low Resource Setting. Indian Journal of Gynecologic Oncology , 16(4), p.64.

Mabeya, H., et al., 2018. Uptake of three doses of HPV vaccine by primary school girls in Eldoret, Kenya; a prospective cohort study in a malaria endemic setting. BMC Cancer , 2018 18:557(https://doi.org/10.1186/s12885-018-4382-x).

Orang'o, E.O., et al., 2017. Comparison of VIA with molecular testing using HPV DNA and the biomarker p16INK4a/Ki67 for cervical cancer screening in a high prevalent cervical cancer setting. In Eurogin 2017. October 9, 2017. Amsterdam, Netherlands, p. Abstract number #00529 .

Orang'o, E.O., et al., 2017. Design and Implementation of an electronic data system for cervical cancer Screening in peripheral settings in Kenya. . In Eurogin 2017. October 10, 2017. Amsterdam, Netherlands, p. Abstract number #00526.

Barry, R., et al., 2017. Development of a comprehensive and sustainable gynaecologic oncology training program in western Kenya, a low resource setting. Gynecologic oncology reports, 21, p.122-127.

Nyambura, M.G., Kiarie, J.N. & Orang’o, O., 2017. Knowledge and Utilisation of Emergency Contraception Pills among Female Undergraduate Students at the University of Nairobi, . Open Journal of Obstetrics and Gynaecology, 7(9), p.989-1005.

Orang'o, E.O., et al., 2017. Palliative Cisplatinum for advanced cervical cancer: A case of MTRH. In 41ST Annual Scientific Conference of the Kenya Obstetrical and Gynaecological Society (KOGS). February16, 2017. PrideInn Paradise Beach Resort & Spa, Mombasa.

Kirui, S., Patel, K. & Orang'o, E.O., 2017. Prevalence of high risk HPV in HIV+ and HIV-women with cervical dysplasia at the Moi Teaching and Referral Hospital. East African Medical Journal, 94(11), p.891-900.

Randall, T.C., et al., 2017. Strengthening care and research for women's cancers in Sub-Saharan Africa. Gynecologic oncology reports, 21, p.109.

Orang’o, E.O., et al., 2017. Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities. AIDS, 31(2), p.233-240.

Orang'o, E.O., et al., 2017. VIA, PAP Smear and HR-HPV Testing in Women with HIV/AIDS for Post-Treatment Cervical Cancer Screening: Same Tests, Different Priorities. In 31St International Papillomavirus Conference- HPV 2017. February28, 2018. Cape Town, South Africa, p. Abstract Number: HPV17-0044 .

Orang'o, E.O., et al., 2016. Cervical Cancer from Early Diagnosis to Advanced Disease: Lofty Goals and on-the-ground Realities. In World Cancer Congress. November2, 2016. Paris, France.

Orang'o, E.O., et al., 2016. Factors Associated with Uptake of Visual Inspection with Acetic Acid (VIA) for Cervical Cancer Screening in Western Kenya. PloS one, 11(6), p.e0157217.

Ermel, A., et al., 2016. Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications. infectious Agents and Cancer , 11(1), p.56.

G, G., et al., 2016. Perioperative Complications Of Radical Hysterectomy At Moi Teaching And Referral Hospital, A Low Resource Setting-A 5 Year R.. International Journal of Gynaecological Cancer , 26, p.344-344.

Chau, D., et al., 2016. Post-LEEP Surveillance in HIV-Positive and HIV-Negative Women in Western Kenya. In 16Th Biennial Meeting of the International Gynecologic Cancer Society (IGCS). October 29, 2016. Lisbon, Portugal, p. Abstract Number IGCS-1011.

Orang’o, E.O., et al., 2016. Use of Palliative Cisplatinum for Advanced Cervical Cancer in a Resource-Poor Setting: A Case Series From Kenya. Journal of Global Oncology , 3(5), p.539-544.